Magnetic resonance imaging–ultrasound fusion-targeted biopsy combined with systematic 12-core ultrasound-guided biopsy improves the detection of clinically significant prostate cancer: Are we ready to abandon the systematic approach?

Magnetic resonance imaging–ultrasound fusion-targeted biopsy combined with systematic 12-core ultrasound-guided biopsy improves the detection of clinically significant prostate cancer: Are we ready to abandon the systematic approach?

Background: Multiparametric (mp) magnetic resonance imaging (MRI)–ultrasound fusion-targeted biopsy (TB) has improved the detection of clinically significant prostate cancer (csCaP) using the Prostate Imaging Reporting and Data System (PI-RADS) reporting system, leading some authors to conclude that...

Full description

Bibliographic Details
Main Authors: Christopher Antonio Febres-Aldana, Sarah Alghamdi, Thomas A Weppelmann, Emilio Lastarria, Akshay Bhandari, Yumna Omarzai, Robert J Poppiti
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Urology Annals
Subjects:
cancer detection
fusion targeted biopsy
multiparametric magnetic resonance imaging
prostate biopsy
prostate cancer
Online Access:http://www.urologyannals.com/article.asp?issn=0974-7796;year=2020;volume=12;issue=4;spage=366;epage=372;aulast=Febres-Aldana

Internet

http://www.urologyannals.com/article.asp?issn=0974-7796;year=2020;volume=12;issue=4;spage=366;epage=372;aulast=Febres-Aldana

Similar Items